Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol

Added 80 days ago (14.09.2021)
Authors: Tavernier, E., Barbier, F., Meziani, F., Quenot, J.-P., Herbrecht, J.-E., Landais, M., Roux, D., Seguin, P., Schnell, D., Veinstein, A., Veber, B., Lasocki, S., Lu, Q., Beduneau, G., Ferrandiere, M., Dahyot-Fizelier, C., Plantefeve, G., Nay, M.-A., Merdji, H., Andreu, P., Vecellio, L., Muller, G., Cabrera, M., Le Pennec, D., Respaud, R., Lanotte, P., Gregoire, N., Leclerc, M., Helms, J., Boulain, T., Lacherade, J.-C., Ehrmann, S., On behalf of the REVA network and the CRICS-TRIGGESEP F-CRIN network
Journal: BMJ Open
Read article